<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02288026</url>
  </required_header>
  <id_info>
    <org_study_id>D14110700020000</org_study_id>
    <nct_id>NCT02288026</nct_id>
  </id_info>
  <brief_title>Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Chest Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare early-stage peripheral non-small cell lung cancer
      lobectomy and sub-lobectomy surgery to evaluate if sub-lobectomy is as feasible and effective
      for the treatment of early-stage (diameter ≤2cm) peripheral non-small cell lung cancer as
      lobectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:To establish a database of patients with early lung cancer surgery,and evaluate if
      sub-lobectomy surgery is as feasible and effective as lobectomy surgery in patients with
      early-stage peripheral non-small cell lung cancer,by assessing the retainability of lung
      function.and improvement of quality of life in those patients.

      Outline:This is a prospective, matched, controlled, open, multi-center clinical study. Select
      the early-stage peripheral NSCLC 630 patients (diameter≤2cm), according to age and lesion
      type (GGO component ratio) two matching factor of 1: 2 assigned to sub-lobectomy group and
      lobectomy group.Patients are followed up every 3 months for the first year and then every 6
      months for the other 4 years.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>participants will be followed from surgical treatment at least 5 years unless any evidence of disease progression or death</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>at least 5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function</measure>
    <time_frame>Forced expiratory volume in one second, FEV1</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">630</enrollment>
  <condition>Stage IA Non-small Cell Lung Cancer</condition>
  <condition>Adenocarcinoma of the Lung</condition>
  <condition>Squamous Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Arm I</arm_group_label>
    <description>Patients undergo lobectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II</arm_group_label>
    <description>Patients undergo a wedge resection or anatomical segmentectomy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients are stratified according to age and lesion type (GGO component ratio) two matching
        factor of 1: 2 to the lobectomy and sub-lobectomy surgery groups.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. clinically diagnosed with stage I peripheral non-small cell lung cancer suitable for
             lobectomy.

          2. T≤2cm，N0，M0.

          3. aged 60 to 80 years old.

          4. ECOG≤2.

          5. according to the Ministry of Health, &quot;with primary lung cancer diagnostic and
             treatment practices&quot; (2011 edition) completed preoperative clinical staging
             examination.

          6. voluntary participation, signed informed consent.

        Exclusion Criteria:

          1. pathologic stage is N1, N2, or M1a.

          2. received postoperative adjuvant therapy (chemotherapy or targeted therapy).

          3. radiotherapy or chemotherapy before surgery.

          4. small cell lung cancer

          5. benign lesions

          6. patient unwilling to cooperate with surgery or observation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiuyi Zhi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Xuanwu Hospital, Beijing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiuyi Zhi</last_name>
    <phone>+86 10 83198287</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mu Hu</last_name>
    <phone>+86 10 83198646</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xuanwu hospital capital medical university</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuyi Zhi</last_name>
      <phone>+86 10 83198287</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2014</study_first_submitted>
  <study_first_submitted_qc>November 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2014</study_first_posted>
  <last_update_submitted>November 7, 2014</last_update_submitted>
  <last_update_submitted_qc>November 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>Xiuyi zhi</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Carcinoma, Non-Small-Cell Lung</keyword>
  <keyword>Lung Neoplasms</keyword>
  <keyword>Carcinoma, Bronchogenic</keyword>
  <keyword>Bronchial Neoplasms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

